Thermo Fisher Scientific Inc.
- Stock
- Ticker TMO
- ISIN US8835561023
- NYSE
Performance, volatility and drawdowns of Thermo Fisher Scientific Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $47,118. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −41.0% in 06/2025, measured from the peak in 12/2021. It took 57 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 11,395 | 10,364 | 10,855 | 11,122 | 12,215 | 11,005 | 11,994 | 12,137 |
| Operating income | 2,016 | 1,716 | 1,834 | 1,941 | 2,255 | 1,863 | 2,087 | 2,263 |
| EBITDA | 2,320 | 1,992 | 2,090 | 2,168 | 2,547 | 2,169 | 2,418 | 2,570 |
| Net income | 1,830 | 1,507 | 1,617 | 1,616 | 1,964 | 1,651 | 1,736 | 1,721 |
| Earnings per share | 4.78 | 3.98 | 4.28 | 4.27 | 5.21 | 4.43 | 4.68 | 4.64 |
| Balance sheet | ||||||||
| Total assets | 97,321 | 99,041 | 101,230 | 103,020 | 110,343 | 113,281 | 113,174 | 114,233 |
| Liabilities | 47,770 | 49,684 | 50,754 | 51,996 | 56,928 | 61,341 | 60,488 | 59,466 |
| Equity | 49,584 | 49,390 | 50,512 | 51,018 | 53,407 | 51,934 | 52,679 | 54,761 |
| Cash | 4,009 | 4,134 | 4,576 | 1,982 | 9,852 | 3,254 | 4,064 | 5,461 |
| Long-term debt | 31,072 | 33,989 | 35,033 | 35,484 | 39,172 | 42,947 | 42,284 | 41,108 |
| Cash flow | ||||||||
| Operating cash flow | 3,290 | 723 | 1,399 | 2,239 | 3,457 | 1,192 | 2,125 | 2,550 |
| Capital expenditure | -480 | -362 | -294 | -404 | -465 | -376 | -450 | -437 |
| Free cash flow | 2,810 | 361 | 1,105 | 1,835 | 2,992 | 816 | 1,675 | 2,113 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2019 at +45.5%, weakest 2022 at −17.3%. 6 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 30 Oct 2026 | $4.64 |
| 31 Jul 2026 | $4.68 |
| 1 May 2026 | $4.43 |
| 26 Feb 2026 | $5.21 |
| 31 Oct 2025 | $4.27 |
| 1 Aug 2025 | $4.28 |
| 2 May 2025 | $3.98 |
| 20 Feb 2025 | $4.78 |
| 1 Nov 2024 | $4.25 |
| 2 Aug 2024 | $4.04 |
| 3 May 2024 | $3.46 |
| 22 Feb 2024 | $4.20 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €225bn
- Market cap in trading currency
- $248bn
- Enterprise value
- $283bn
- P/E
- 35.3
- P/S
- 5.24
- P/B
- 4.53
- EV/Sales
- 5.98
- EV/EBITDA
- 29.2
- Earnings yield
- 2.8%
- FCF yield
- 3.1%
Results (last four quarters)
- Revenue
- $47.4bn
- Gross profit
- –
- EBITDA
- $9.70bn
- Net income
- $7.07bn
- Earnings per share
- $18.96
- Revenue per share
- $127.80
- Revenue growth
- +9.1%
- Earnings growth
- +6.5%
Profitability
- Gross margin
- –
- Operating margin
- 17.9%
- Net margin
- 14.9%
- Return on equity
- 13.4%
- Return on assets
- 6.2%
Balance sheet and cash flow
- Cash
- $6.06bn
- Cash per share
- $16.36
- Financial debt
- $41.1bn
- Debt/equity %
- 75
- Current ratio
- 1.81
- Book value per share
- $147.80
- Operating cash flow
- $9.32bn
- Free cash flow
- $7.60bn
Dividend
- Dividend yield
- 0.27%
- Dividend (12 months)
- $1.84
- Yield (12 months)
- 0.27%
- Payout ratio
- 10%
- Ex-dividend date
- 15 Sep 2026
Shares and trading
- Shares outstanding
- 371m
- Volume
- 2.35m
- Avg. volume 3 months
- 2.17m
- Relative volume
- 1.1
Price and technicals
- Price
- $669.54
- 1 day
- −2.8%
- 52-week high
- $721.63
- 52-week low
- $438.34
- Distance to 52-week high
- −7.2%
- Distance to 52-week low
- +52.7%
- Distance to 50-day line
- −1.3%
- Distance to 200-day line
- +19.9%
- RSI (14)
- 43
- Volatility 1M
- 31.3%
Performance
- 1 week
- −4.4%
- 1 month
- −1.0%
- 3 months
- +6.5%
- 6 months
- +49.4%
- YTD
- +15.5%
- 1 year
- +16.7%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 26 Sep 2026
Frequently asked questions
How has TMO performed since 11/2016?
$10,000 grew to $47,118 by 20 Nov 2026, which is +16.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is TMO?
Volatility was 23.6% per year, measured on monthly returns. The largest decline from a peak was −41.0%, with the low in 06/2025.
How does TMO compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, TMO returned +16.8% at 23.6%. The correlation of monthly returns was 0.50; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.